James A. Cardelli

Affiliations: 
Louisiana State University Health Sciences Center - Shreveport 
Area:
Cell Biology, Molecular Biology
Google:
"James Cardelli"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dykes SS, Steffan JJ, Cardelli JA. (2017) Lysosome trafficking is necessary for EGF-driven invasion and is regulated by p38 MAPK and Na+/H+ exchangers. Bmc Cancer. 17: 672
Circu M, Cardelli J, Barr MP, et al. (2017) Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells. Plos One. 12: e0184922
Tournu H, Carroll J, Latimer B, et al. (2017) Identification of small molecules that disrupt vacuolar function in the pathogen Candida albicans. Plos One. 12: e0171145
Dykes SS, Gao C, Songock WK, et al. (2016) Zinc finger E-box binding homeobox-1 (Zeb1) drives anterograde lysosome trafficking and tumor cell invasion via upregulation of Na+/H+ exchanger-1 (NHE1). Molecular Carcinogenesis
Mohyeldin MM, Busnena BA, Akl MR, et al. (2016) Novel c-Met inhibitory olive secoiridoid semisynthetic analogs for the control of invasive breast cancer. European Journal of Medicinal Chemistry. 118: 299-315
Gray AL, Coleman DT, Shi R, et al. (2016) Monocarboxylate transporter 1 contributes to growth factor-induced tumor cell migration independent of transporter activity. Oncotarget
Dykes SS, Gray AL, Coleman DT, et al. (2016) The Arf-like GTPase Arl8b is essential for three-dimensional invasive growth of prostate cancer in vitro and xenograft formation and growth in vivo. Oncotarget
Mohyeldin MM, Akl MR, Ebrahim HY, et al. (2016) The oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitor. Oncotarget
Coleman DT, Gray AL, Kridel SJ, et al. (2016) Palmitoylation regulates the intracellular trafficking and stability of c-Met. Oncotarget
Coleman DT, Gray AL, Stephens CA, et al. (2016) Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation. Oncotarget
See more...